It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
School-age boys are now being advised to get vaccinated with Gardasil, Merck’s cervical cancer vaccine, according to mainstream media reports. Previously, the vaccine was only recommended for girls.
The new male recommendation is based on the notion that boys could get throat cancer if they have oral sex with an HPV-infected girl.
According to some, however, recommending Gardasil to boys is little more than a scare campaign aimed at gaining market share from teenage boys.
According to NVIC's report, a majority of Gardasil adverse event reports to VAERS involved those who suffered fever, nausea, headache or pain; 14 percent were for syncopal episodes with or without neurological signs; and 8 percent experienced tingling, numbness and loss of sensation, facial paralysis or Guillain-Barre Syndrome. Although adverse event reports to VAERS do not prove causation, they can provide an early warning sign that a new vaccine may be causing health problems that could be important. For example, reports to VAERS of bowel blockage (intussusception) in babies following receipt of Merck's Rota Teq (rotavirus) vaccine prompted the FDA to issue a public warning to doctors and consumers on Feb. 13.
NVIC also found that there were several VAERS reports of HPV infection, genital warts and cervical lesions after Gardasil vaccination. It is unknown if the girls were infected with HPV before being vaccinated or if Gardasil failed to protect them. One case of HPV infection occurred in a 22-year-old girl who had participated in a Merck Gardasil trial in 2003 when she had shown "strong conversion to all 4 vaccine types" but "tested positive for high risk HPV" in 2006, according to the VAERS report.*